Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
CNTA
CNTA News & Events
-
Add to Watchlist
Trade CNTA Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
CNTA News
Pharmaceutical Giants Accelerate Acquisitions to Offset Patent Cliffs
Jun 05 2026
stocktwits
Eli Lilly Actively Pursuing Acquisition Opportunities
Jun 03 2026
CNBC
Eli Lilly Accelerates Acquisition Strategy Fueled by GLP-1 Drug Success
Jun 03 2026
Newsfilter
Investor Rights Law Firm Investigates Multiple Companies
May 27 2026
Globenewswire
Investor Rights Law Firm Investigates Multiple Companies
May 19 2026
PRnewswire
Investor Rights Law Firm Investigates Multiple Companies
May 12 2026
PRnewswire
Eli Lilly's Dominance in Weight Loss Market
Apr 28 2026
Fool
Eli Lilly's Leadership in the Weight Loss Market
Apr 28 2026
NASDAQ.COM
Show More News
CNTA Events
06/04 15:00
Centessa Pharmaceuticals' Cleminorexton Receives FDA Orphan Designation
Centessa Pharmaceuticals' cleminorexton was granted FDA orphan designation as a treatment of idiopathic hypersomnia, according to a post to the agency's website.
Show More Events
CNTA Monitor News
Eli Lilly to Acquire Centessa Pharmaceuticals for $38 per Share
Mar 31 2026
CNTA Earnings Analysis
No Data
People Also Watch
